CoChat

Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries

Open access
Vedanthan, Rajesh, Bernabe-Ortiz, Antonio, Herasme, Omarys I., Joshi, Rohina, Lopez-Jaramillo, Patricio, Thrift, Amanda G., Webster, Jacqui, Webster, Ruth, Yeates, Karen, Gyamfi, Joyce, Ieremia, Merina, Johnson, Claire, Kamano, Jemima H., Lazo-Porras, Maria, Limbani, Felix, Liu, Peter, McCready, Tara, Miranda, J. Jaime, Mohan, Sailesh, Ogedegbe, Olugbenga, Oldenburg, Brian, Ovbiagele, Bruce, Owolabi, Mayowa, Peiris, David, Ponce-Lucero, Vilarmina, Praveen, Devarsetty, Pillay, Arti, Schwalm, Jon-David, Tobe, Sheldon W., Trieu, Kathy, Yusoff, Khalid, Fuster, Valentin · 2017 · Cardiology Clinics
Cited by 73

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Elevated blood pressure, a major risk factor for ischemic heart disease, heart failure, and stroke, is the leading global risk for mortality. Despite global efforts to combat hypertension, it continues to exert a significant health and economic burden on low- and middle-income country (LMIC) populations, thereby triggering the need to address the problem by way of novel approaches. The Global Alliance for Chronic Diseases has funded 15 research projects related to hypertension control in low-resource settings worldwide. These research projects have developed and evaluated several important innovative approaches to hypertension control, including: community engagement, salt reduction, salt substitution, task redistribution, mHealth, and fixed-dose combination therapies. In this paper, we briefly review the rationale for each of these innovative approaches, as well as summarize the experience of some of the research teams in these respective areas. Where relevant, we also draw upon the wider literature to illustrate how these approaches to hypertension control are being implemented in LMICs. The studies outlined in this report demonstrate innovative and practical methods of implementing for improving hypertension control in diverse environments and contexts worldwide.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccl.2016.08.010

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Research works printed but not linked: 51

  1. Lim, 2012, A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010, Lancet, 380, 2224, 10.1016/S0140-6736(12)61766-8 · DOI · Paper page
  2. Lewington, 2002, Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet, 360, 1903, 10.1016/S0140-6736(02)11911-8 · DOI · Paper page
  3. Chow, 2013, Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries, JAMA, 310, 959, 10.1001/jama.2013.184182 · DOI · Paper page
  4. W Tobe, 2016, The Global Alliance for Chronic Diseases supports 15 major studies in hypertension prevention and control in low- and middle-income countries, J Clin Hypertens (Greenwich), 18, 600, 10.1111/jch.12835 · DOI
  5. Khatib, 2014, Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies, PLoS One, 9, e84238, 10.1371/journal.pone.0084238 · DOI · Paper page
  6. Digiacomo, 2010, Facilitating uptake of aboriginal adult health checks through community engagement and health promotion, Qual Prim Care, 18, 57
  7. Marston, 2013, Effects of community participation on improving uptake of skilled care for maternal and newborn health: a systematic review, PLoS One, 8, e55012, 10.1371/journal.pone.0055012 · DOI
  8. Vedanthan, 2014, Optimizing linkage and retention to hypertension care in rural Kenya (LARK hypertension study): study protocol for a randomized controlled trial, Trials, 15, 143, 10.1186/1745-6215-15-143 · DOI
  9. Naanyu, 2016, Barriers influencing linkage to hypertension care in Kenya: qualitative analysis from the LARK hypertension study, J Gen Intern Med, 31, 304, 10.1007/s11606-015-3566-1 · DOI
  10. Maar, 2015, I-RREACH: an engagement and assessment tool for improving implementation readiness of researchers, organizations and communities in complex interventions, Implement Sci, 10, 64, 10.1186/s13012-015-0257-6 · DOI
  11. Bradley, 2007, Prevention of hypertension and diabetes in an urban setting in South Africa: participatory action research with community health workers, Ethn Dis, 17, 49
  12. Balcazar, 2009, A randomized community intervention to improve hypertension control among Mexican Americans: using the promotoras de salud community outreach model, J Health Care Poor Underserved, 20, 1079, 10.1353/hpu.0.0209 · DOI
  13. Webster, 2016, Salt intakes, knowledge, and behavior in Samoa: monitoring salt-consumption patterns through the World Health Organization’s surveillance of noncommunicable disease risk factors (STEPS), J Clin Hypertens (Greenwich), 18, 884, 10.1111/jch.12778 · DOI
  14. Webster, 2014, Cost-effectiveness of reducing salt intake in the Pacific Islands: protocol for a before and after intervention study, BMC Public Health, 14, 107, 10.1186/1471-2458-14-107 · DOI
  15. He, 2015, School based education programme to reduce salt intake in children and their families (School-EduSalt): cluster randomised controlled trial, BMJ, 350, h770, 10.1136/bmj.h770 · DOI · Paper page
  16. Peng, 2014, Effects of salt substitutes on blood pressure: a meta-analysis of randomized controlled trials, Am J Clin Nutr, 100, 1448, 10.3945/ajcn.114.089235 · DOI
  17. Bernabe-Ortiz, 2014, Launching a salt substitute to reduce blood pressure at the population level: a cluster randomized stepped wedge trial in Peru, Trials, 15, 93, 10.1186/1745-6215-15-93 · DOI
  18. Saavedra-Garcia, 2015, Applying the triangle taste test to assess differences between low sodium salts and common salt: evidence from Peru, PLoS One, 10, e0134700, 10.1371/journal.pone.0134700 · DOI
  19. Salt substitution, 2007, A low-cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial, J Hypertens, 25, 2011, 10.1097/HJH.0b013e3282b9714b · DOI · Paper page
  20. Zhou, 2009, Compound ion salt, a novel low-sodium salt substitute: from animal study to community-based population trial, Am J Hypertens, 22, 934, 10.1038/ajh.2009.135 · DOI
  21. Zhao, 2014, Using a low-sodium, high-potassium salt substitute to reduce blood pressure among Tibetans with high blood pressure: a patient-blinded randomized controlled trial, PLoS One, 9, e110131, 10.1371/journal.pone.0110131 · DOI · Paper page
  22. Deller, 2015, Task shifting in maternal and newborn health care: key components from policy to implementation, Int J Gynecol Obstet, 130, S25, 10.1016/j.ijgo.2015.03.005 · DOI
  23. Dawson, 2014, Task shifting and sharing in maternal and reproductive health in low-income countries: a narrative synthesis of current evidence, Health Policy Plan, 29, 396, 10.1093/heapol/czt026 · DOI · Paper page
  24. World Health Organization (WHO). Task shifting to tackle health worker shortages. Geneva (Switzerland): WHO Press; 2007.
  25. Lekoubou, 2010, Hypertension, diabetes mellitus and task shifting and their management in sub-Saharan Africa, Int J Environ Res Public Health, 7, 353, 10.3390/ijerph7020353 · DOI · Paper page
  26. Ogedegbe, 2014, Task shifting interventions for cardiovascular risk reduction in low-income and middle-income countries: a systematic review of randomised controlled trials, BMJ Open, 4, e005983, 10.1136/bmjopen-2014-005983 · DOI · Paper page
  27. Akinyemi, 2015, Task-shifting training improves stroke knowledge among Nigerian non-neurologist health workers, J Neurol Sci, 359, 112, 10.1016/j.jns.2015.10.019 · DOI
  28. Joshi, 2012, The rural Andhra Pradesh cardiovascular prevention study, J Am Coll Cardiol, 59, 1188, 10.1016/j.jacc.2011.10.901 · DOI
  29. Kar, 2008, Cardiovascular disease risk management in a primary health care setting of north India, Indian Heart J, 60, 19
  30. Jafar, 2010, Community based lifestyle intervention for blood pressure reduction in children and young adults in developing country: cluster randomised controlled trial, BMJ, 340, c2641, 10.1136/bmj.c2641 · DOI
  31. Xavier, 2016, Community health worker-based intervention for adherence to drugs and lifestyle change after acute coronary syndrome: a multicentre, open, randomised controlled trial, Lancet Diabetes Endocrinol, 4, 244, 10.1016/S2213-8587(15)00480-5 · DOI
  32. Gaziano, 2015, Cardiovascular disease screening by community health workers can be cost-effective in low-resource countries, Health Aff (Millwood), 34, 1538, 10.1377/hlthaff.2015.0349 · DOI · Paper page
  33. Thorogood, 2014, The Nkateko health service trial to improve hypertension management in rural South Africa: study protocol for a randomised controlled trial, Trials, 15, 435, 10.1186/1745-6215-15-435 · DOI
  34. Ogedegbe, 2014, A cluster-randomized trial of task shifting and blood pressure control in Ghana: study protocol, Implement Sci, 9, 73, 10.1186/1748-5908-9-73 · DOI
  35. Praveen, 2013, A multifaceted strategy using mobile technology to assist rural primary healthcare doctors and frontline health workers in cardiovascular disease risk management: protocol for the SMARTHealth India cluster randomised controlled trial, Implementation Sci, 8, 137, 10.1186/1748-5908-8-137 · DOI · Paper page
  36. Piette, 2015, Mobile health devices as tools for worldwide cardiovascular risk reduction and disease management, Circulation, 132, 2012, 10.1161/CIRCULATIONAHA.114.008723 · DOI · Paper page
  37. Peiris, 2014, Use of mHealth systems and tools for non-communicable diseases in low- and middle-income countries: a systematic review, J Cardiovasc Transl Res, 7, 677, 10.1007/s12265-014-9581-5 · DOI
  38. Okoro, 2010, Mobile phone ownership among Nigerians with diabetes, Afr Health Sci, 10, 183
  39. Owolabi, 2014, Randomized controlled trial of a multipronged intervention to improve blood pressure control among stroke survivors in Nigeria, Int J Stroke, 9, 1109, 10.1111/ijs.12331 · DOI
  40. Cushman, 2008, Blood pressure control by drug group in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT), J Clin Hypertens, 10, 751, 10.1111/j.1751-7176.2008.00015.x · DOI
  41. Johnston, 2010, Effectiveness, safety and cost of drug substitution in hypertension, Br J Clin Pharmacol, 70, 320, 10.1111/j.1365-2125.2010.03681.x · DOI
  42. Shaw, 1995, Factors associated with noncompliance of patients taking antihypertensive medications, Hosp Pharm, 30, 201
  43. Faria, 2009, A narrative review of clinical inertia: focus on hypertension, J Am Soc Hypertens, 3, 267, 10.1016/j.jash.2009.03.001 · DOI
  44. Brown, 2011, Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial, Lancet, 377, 312, 10.1016/S0140-6736(10)62003-X · DOI · Paper page
  45. Gupta, 2010, Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis, Hypertension, 55, 399, 10.1161/HYPERTENSIONAHA.109.139816 · DOI · Paper page
  46. Webster, 2016, Effectiveness of fixed dose combination medication (‘polypills’) compared with usual care in patients with cardiovascular disease or at high risk: a prospective, individual patient data meta-analysis of 3140 patients in six countries, Int J Cardiol, 205, 147, 10.1016/j.ijcard.2015.12.015 · DOI
  47. Lonn, 2016, Blood-pressure lowering in intermediate-risk persons without cardiovascular disease, N Engl J Med, 374, 2009, 10.1056/NEJMoa1600175 · DOI · Paper page
  48. Yusuf, 2016, Blood-pressure and cholesterol lowering in persons without cardiovascular disease, N Engl J Med, 374, 2032, 10.1056/NEJMoa1600177 · DOI · Paper page
  49. Salam, 2014, TRIple pill vs Usual care Management for Patients with mild-to-moderate Hypertension (TRIUMPH): study protocol, Am Heart J, 167, 127, 10.1016/j.ahj.2013.10.020 · DOI
  50. Patel, 2015, A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk, Eur J Prev Cardiol, 22, 920, 10.1177/2047487314530382 · DOI · Paper page
  51. Selak, 2014, Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care, BMJ, 348, g3318, 10.1136/bmj.g3318 · DOI · Paper page

Cited by

Metadata

Authors
Vedanthan, R., Bernabe-Ortiz, A., Herasme, O. I., Joshi, R., Lopez-Jaramillo, P., Thrift, A. G., Webster, J., Webster, R., Yeates, K., Gyamfi, J., Ieremia, M., Johnson, C., Kamano, J. H., Lazo-Porras, M., Limbani, F., Liu, P., McCready, T., Miranda, J. J., Mohan, S., Ogedegbe, O., Oldenburg, B., Ovbiagele, B., Owolabi, M., Peiris, D., Ponce-Lucero, V., Praveen, D., Pillay, A., Schwalm, J.-D., Tobe, S. W., Trieu, K., Yusoff, K., & Fuster, V.
Venue
Cardiology Clinics
Publisher
Elsevier BV
Published
2017-02
Volume
35
Issue
1
Pages
99-115
ISSN
0733-8651 (ISSN-L)
OpenAlex
W2554522310
Cited by
73
References
17
FWCI
3.74
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • Canadian Institutes of Health Research (120389)
  • Grand Challenges Canada (0069-04, 0070-04)
  • International Development Research Centre
  • Canadian Stroke Network
  • Australian National Health and Medical Research Council (1040147, 104018)
  • US National Institutes of Health (U01 HL114200, U01 NS079179, U01 HL114180)
  • United Kingdom Medical Research Council (APP 1040179, APP 1041052, J01 60201)
  • Malaysian Ministry of Higher Education

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.